Etonogestrel implant
Etonogestrel implant is a pharmaceutical drug with 12 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
9 of 9 finished
0.0%
0 ended early
2
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Etonogestrel Implant as Emergency Contraception
Endometrial Biopsy in Progestin Contraceptive Users
Pharmacologic Strategies for the Etonogestrel Implant in HIV-Infected Women
The Use of Etonogestrel Contraceptive Implant as Treatment for Endometrial Hyperplasia Without Atypia: A Cohort Study
Clinical Trials (12)
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Etonogestrel Implant as Emergency Contraception
Endometrial Biopsy in Progestin Contraceptive Users
Pharmacologic Strategies for the Etonogestrel Implant in HIV-Infected Women
The Use of Etonogestrel Contraceptive Implant as Treatment for Endometrial Hyperplasia Without Atypia: A Cohort Study
Impact of Contraceptives on Cervico-Vaginal Mucosa
Shoulder Contraceptive Implant Study
Assessing Ovarian Function During Prolonged Implant Use
Effectiveness of Prolonged Use of IUD/Implant for Contraception
Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy Women
Same-day Long-acting Reversible Contraception for Medication Abortion
Immediate vs. Delayed Postpartum Etonogestrel Implant
All 12 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 12